CytomX Therapeutics, Inc.

By person

25 insiders · 165 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

THIRD ROCK VENTURES LP entity

10% owner

—

$28.70M (2)

−$28.70M

85,509

$260.80K

−98.4%

McCarthy Sean A.

CEO

—

$8.58M (40) scheduled

−$8.58M

2,159,971

$6.59M

+104.8%

Canaan IX L.P.

Director

—

$3.42M (14)

−$3.42M

2,494,381

$7.61M

−41.2%

SHANNON TIMOTHY M

Director

—

$3.42M (14)

−$3.42M

3,244,829

$9.90M

−8.5%

RAY DEBANJAN

Chief Financial Officer

—

$1.98M (21) scheduled

−$1.98M

5,928

$18.08K

−73.0%

GLUCK FREDERICK W

Director

—

$1.52M (8)

−$1.52M

289,154

$881.92K

−19.0%

TEPPER ROBERT I

10% owner

—

$1.20M (3)

−$1.20M

4,349,864

$13.27M

−1.4%

HUMPHREY RACHEL

Chief Medical Officer

—

$1.20M (2) scheduled

−$1.20M

30,234

$92.21K

—

Kavanaugh William Michael

CSO, Head Res.&Non-Clin. Dev.

—

$1.18M (1) scheduled

−$1.18M

81,332

$248.06K

+6.7%

STARR KEVIN P

10% owner

—

$463.79K (1)

−$463.79K

5,201,767

$15.87M

−0.5%

Goeltz II Robert C.

Chief Financial Officer

—

$426.34K (2) scheduled

−$426.34K

32,756

$99.91K

+1,538%

BELVIN MARCIA

SVP, Chief Scientific Officer

—

$294.10K (7)

−$294.10K

300,760

$917.32K

+250.5%

Ogden Christopher

Chief Financial Officer

—

$179.97K (9)

−$179.97K

295,324

$900.74K

+1,431%

Chu Yu-Waye

Chief Medical Officer

—

$139.09K (2)

−$139.09K

189,446

$577.81K

—

ROWLAND LLOYD A

General Counsel

$92.97K (1)

$47.00K (7)

+$45.97K

120,594

$367.81K

+483.8%

Landau Jeffrey B

Chief Business Officer

—

$38.71K (6)

−$38.71K

119,056

$363.12K

+315.1%

Peterson Amy C.

EVP, Chief Development Officer

—

$19.04K (2)

−$19.04K

58,433

$178.22K

+1,466%

Campoy Carlos

Chief Financial Officer

—

$9.08K (2)

−$9.08K

38,224

$116.58K

—

HANNAH ALISON L.

Chief Medical Officer

—

$7.97K (1)

−$7.97K

31,898

$97.29K

—

Jones Elaine V

Director

$7.75K (1)

—

+$7.75K

5,142

$15.68K

+3,521%

Exter Neil

Director

—

— (2)

$0.00

11,199

$34.16K

0.0%

BVF PARTNERS L P/IL entity

See Explanation of Responses

—

358,450

$1.09M

0.0%

Carvajal Alejandra

Chief Legal Officer

—

100,000

$305.00K

—

Lester Rachael

Chief Business Officer

—

20,000

$61.00K

—

Knifsend Robin

Principal Accounting Officer

—

2,791

$8.51K

+185.1%

No percentages here. This company's share count has moved by a factor of 2.8 over the window, from 78,258,879 to 217,899,284 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

CytomX Therapeutics, Inc.

By person

Individual transactions

What was left out